Why the study?
Does a fixed-dose combination of antihypertensive drugs improve health-related quality of life and emotional burden in patients with uncontrolled hypertension?
Does a fixed-dose combination of antihypertensive drugs improve health-related quality of life and emotional burden in patients with uncontrolled hypertension?
Effective management of hypertension with a fixed-dose combination improves health-related quality of life and reduces emotional burden.
BP control linked to better self-reported health in this cohort; leaves open whether fixed-dose combinations causally improve quality of life.
Often considered to be a symptomless condition, hypertension can be associated with a significant emotional burden. To analyze changes of health-related quality of life as well as the emotional burden questions regarding the impact of hypertension were incorporated into the noninterventional SeviTarget study. Comparisons were made between baseline and follow-up findings, and between patients with treatment target achievement and those without. A total of 5831 patients were recruited. At baseline, only 33.3% of patients described their current state of health as good or excellent, while at follow-up this value had risen to 75.8%. Responses regarding symptoms and limitations in activities and mental factors such as anxiety associated with treatment all improved during antihypertensive treatment. Changes to more optimistic responses were more likely for patients who achieved a target BP of <140/90 mm Hg. The study demonstrates that improvements in quality of life and the perceived emotional burden related to hypertension can be achieved with effective management of hypertension.
No takes yet. Share an insight, caveat, or question.
Schmieder et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: